Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-B7-1 Antibody (3V341)

😃Good
Catalog No. TMAY-03908
Alias CD80 molecule

Anti-B7-1 Antibody (3V341) is a Rabbit antibody targeting B7-1. Anti-B7-1 Antibody (3V341) can be used in ELISA.

Anti-B7-1 Antibody (3V341)

Anti-B7-1 Antibody (3V341)

😃Good
Catalog No. TMAY-03908Alias CD80 molecule
Anti-B7-1 Antibody (3V341) is a Rabbit antibody targeting B7-1. Anti-B7-1 Antibody (3V341) can be used in ELISA.
Pack SizePriceAvailabilityQuantity
100 μL$269 7-10 days
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Antibody Type: Rabbit Monoclonal

Application: ELISA

Reactivity: Cynomolgus, Rhesus
AliasCD80 molecule
Ig Type
Rabbit IgG
Clone
3V341
Reactivity
Cynomolgus, Rhesus
Application
ELISA
Recommended Dose
ELISA: 1:5000-1:10000
Antibody Type
Monoclonal
Host SpeciesRabbit
ConstructionThis antibody was obtained from a rabbit immunized with purified, recombinant Cynomolgus / Rhesus CD80 / B7-1 ( TMPY-04349; ; Met1-Asn242).
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundThe B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD80, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: IHC AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Recombinant Protein: Cynomolgus / Rhesus CD80 / B7-1 Protein (TMPY-04349)
Antigen Species
Cynomolgus, Rhesus
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-B7-1 Antibody (3V341) | purchase Anti-B7-1 Antibody (3V341) | Anti-B7-1 Antibody (3V341) cost | order Anti-B7-1 Antibody (3V341)